Nephrectomy after complete response to immune checkpoint inhibitors for metastatic Renal Cell Carcinoma (mRCC): A new surgical challenge?
The IRON study: Investigation of Robot-assisted versus Open Nephron-sparing surgery
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry
Novel classification model of tumour shape irregularity: Significance for predicting potential oncologic risks in clinically localised renal cell carcinoma
Benchmarking current nephrectomy practice in malignant disease in England: An analysis of the BAUS complex operation registry
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study
The Lancet Oncology, Volume 21, Issue 1, January 2020, Pages 95-104
Beyond the limits of ultrasound: Three dimensional augmented reality robot assisted partial nephrectomy (3D AR-RAPN) for complex renal masses
Nephrectomy after complete response to immune checkpoint inhibitors for metastatic renal cell carcinoma: A new surgical challenge?
European Urology, January 2020
Clinical outcome after radical metastasectomy in renal cell carcinoma: Results from a randomized phase 2 study
November 2019
Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients
September 2019
Quality of life in previously untreated patients with advanced renal cell carcinoma (aRCC) in CheckMate 214: updated results
, September 2019
Advanced clear-cell renal cell carcinoma (accRCC): association of microRNAs (miRNAs) with molecular subtypes, mRNA targets and outcome
September 2019
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More